Wird geladen...
Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
Maintaining bone health remains a clinical challenge in patients with prostate cancer (PC) who are at risk of developing metastatic bone disease and increased bone loss due to hormone ablation therapy. In patients with cancer-treatment induced bone loss (CTIBL), antiresorptive agents have been shown...
Gespeichert in:
| Veröffentlicht in: | Int J Endocrinol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi Publishing Corporation
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4329828/ https://ncbi.nlm.nih.gov/pubmed/25802521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/838202 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|